Inventor · disambiguated record
Peng Cheng
Also filed as: CHENG PENG
15 granted patents·6 pending applications·111 citations·filing 2005–2023
92Inventor score
Top patents by PatentIndex Score
21 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0293US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0391US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 0490US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 0589US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 0686US8183381B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2008·Granted May 22, 2012·13 cites·10 claims
- 0782US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 0879US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 0978US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 1067US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 1164US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 1262US2025305151A1Stabilization treatment liquid for 690 mpa-grade weather-resistant bridge steel member, treatment method and useBAOSHAN IRON & STEEL·Filed 2023·Application pending·0 cites
- 1361US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 1460US10308654B2Preparation and use of kinase inhibitorCHANGZHOU LONGTHERA PHARMACEUTICALS INC·Filed 2016·Granted Jun 4, 2019·1 cites·13 claims
- 1559US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 1658US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 1756US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 1854US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 1947US8846675B2N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersMA JINGYUAN·Filed 2012·Granted Sep 30, 2014·0 cites·22 claims
- 2041US2006014785A1Bicyclic, substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2005·Application pending·0 cites
- 2139US10857517B2Porous chiral materials and uses thereofUNIV NANKAI·Filed 2016·Granted Dec 8, 2020·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Peng Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →